| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 130,161 | 130,364 | 135,041 | 133,041 | | Cost of Revenue | 39,042 | 39,849 | 43,947 | 43,519 | | | Gross Profit | 91,119 | 90,515 | 91,094 | 89,522 | | | Operating Expenses | | Research Development | 22,011 |
-
|
-
| (32,502) | | Selling General and Administrative | 39,912 | 60,817 | 61,150 | 88,235 | | Non Recurring |
-
|
-
|
-
| 322,000 | | Others | 6,354 | 6,287 | 6,252 | 6,204 | | | | Total Operating Expenses |
-
|
-
|
-
| 383,937 | | | | Operating Income or Loss | 22,842 | 23,411 | 23,692 | (294,415) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 1,029 |
-
| (1,925) | | Earnings Before Interest And Taxes | 22,329 | 24,440 | 23,692 | (296,340) | | Interest Expense |
-
| (166) | 166 |
-
| | Income Before Tax | 22,329 | 24,606 | 23,526 | (296,340) | | Income Tax Expense | (2,701) | 9,734 | 10,309 | (40,197) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 25,030 | 14,872 | 13,217 | (256,143) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 4,376 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 25,030 | 14,872 | 13,217 | (251,767) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $25,030 | $14,872 | $13,217 | ($251,767) |
|
0.22% Nasdaq 
Income Statement
